Yüklüyor......

Biomarkers and Surrogate Endpoints In Clinical Trials

One of the most important considerations in designing clinical trials is the choice of outcome measures. These outcome measures could be clinically meaningful endpoints that are direct measures of how patients feel, function and survive. Alternatively, indirect measures, such as biomarkers that incl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Fleming, Thomas R., Powers, John H
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551627/
https://ncbi.nlm.nih.gov/pubmed/22711298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.5403
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!